Project
RHAPSODY
68816ad0-54c1-11eb-9562-acde48001122
Risk Assessment and ProgreSsiOn of Diabetes
Studies
11| Title | Primary purpose | Study type | Organism |
|---|---|---|---|
| RHAPSODY Cohort 1 | Novel biomarkers for diabetes risk | risk and progression of prediabetes and type 2 diabetes | Homo sapiens |
| RHAPSODY Cohort 2 | Novel biomarkers for diabetes risk | risk and progression of prediabetes and type 2 diabetes | Homo sapiens |
| RHAPSODY Cohort 3 | Novel biomarkers for diabetes risk | risk and progression of prediabetes and type 2 diabetes | Homo sapiens |
| RHAPSODY Cohort 4 | Novel biomarkers for diabetes risk | risk and progression of prediabetes and type 2 diabetes | Homo sapiens |
| RHAPSODY Cohort 5 | Novel biomarkers for diabetes risk | risk and progression of prediabetes and type 2 diabetes | Homo sapiens |
| RHAPSODY Cohort 6 | Novel biomarkers for diabetes risk | risk and progression of prediabetes and type 2 diabetes | Homo sapiens |
| RHAPSODY Cohort 7 | Novel biomarkers for diabetes risk | risk and progression of prediabetes and type 2 diabetes | Homo sapiens |
| RHAPSODY Cohort 8 | Novel biomarkers for diabetes risk | risk and progression of prediabetes and type 2 diabetes | Homo sapiens |
| RHAPSODY Cohort 9 | Novel biomarkers for diabetes risk | risk and progression of prediabetes and type 2 diabetes | Homo sapiens |
| RHAPSODY Cohort 10 | Novel biomarkers for diabetes risk | risk and progression of prediabetes and type 2 diabetes | Homo sapiens |
| RHAPSODY Cohort 11 | Novel biomarkers for diabetes risk | risk and progression of prediabetes and type 2 diabetes | Homo sapiens |